• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2013 Health Quality Ontario (HQO) OHTAC recommendation: endovascular ablation for varicose veins
2013 Health Quality Ontario (HQO) Appropriateness phase 1 OHTAC recommendations: annual health exams, aspartate aminotransferase testing, chloride testing, creatine kinase testing, ferritin testing, folate testing, and vitamin B12 testing
2013 Health Quality Ontario (HQO) OHTAC recommendation: midurethral slings for women with stress urinary incontinence
2013 Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013 Agency for Healthcare Research and Quality (AHRQ) Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Mini C-arm imagers for the follow-up of orthopedic patients: clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for rare diseases: evolving trends in regulatory and health technology assessment perspectives
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Copper intra-uterine devices as a contraceptive for adult women: a review of clinical effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Side rails on beds in long-term and residential care facilities: safety and evidence based guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for dental surgery: review of the clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Antipsychotics for the management of agitation in adults with personality disorders or cognitive impairment: a review of the clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Heating standards for clinical interventions: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Transcendental meditation for posttraumatic stress disorder, depression, and anxiety: a review of clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) GreenLight laser for the treatment of benign prostatic hypertrophy: a review of clinical and cost-effectiveness, and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Management of congestive heart failure in primary and community care: guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Procedures and tools for patients at risk for creutzfeldt-jakob disease: guidelines and identification
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Nd:YAG laser for the treatment of patients with hidradenitis suppurativa: a review of the clinical effectiveness, cost-effectiveness, and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Abuse and misuse potential of drugs for attention deficit/hyperactivity disorder: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-steroidal anti-inflammatory drugs for pain: a review of safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Battery replacement and maintenance of deep brain stimulators: guidelines and recommendations
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Misoprostol administration for the treatment of post-partum uterine atony: clinical effectiveness, safety, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Routine blood tests for patients in the intensive care unit: clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Long term Use of Clopidogrel for Patients with Stents or Acute Coronary Syndrome: A Review of Clinical and Cost-effectiveness and Guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Long term use of clopidogrel for patients with stents or acute coronary syndrome: a review of clinical and cost-effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for non-dental surgery: review of the clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Hemolysis and blood infusion pumps for patients receiving blood or blood components: standards and evidence-based guidelines: standards and evidence-based guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgery for obese patients with co-morbidities: a review of clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) O-Arm technology in spinal, neurological, orthopedic, or trauma surgery settings: clinical effectiveness and benefits and harms to patients and hospital staff
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Intraoperative monitoring during spinal or neurological surgeries: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Indigenous knowledge for mental illness and chronic disease: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Management of coronary artery disease in primary and community care: guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Heating standards for magnetic resonance conditional medical devices: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) GreenLight laser for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Community-based programs to improve early childhood health outcomes: guidelines and recommendations
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-steroidal anti-inflammatory drugs for pain: comparative clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Management of chronic obstructive pulmonary disease in primary and community care: guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal in-hospital umbilical cord care for newborns: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal circuit for patients undergoing hemodialysis: safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Peripherally inserted central catheter-associated mast cell activation syndrome: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Mold prevention for hospital bed mattresses: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Supraglottic airway devices in out-of-hospital settings: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Pediatric stretchers and stretcher cribs: safety and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) The use of restraints during acute mental health interventions: a review of the clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Updated reports and recommendations on second- and third-line therapies for type 2 diabetes
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Cefazolin for preoperative prophylaxis in overweight adults having any type of surgery: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Indigenous knowledge for smoking cessation: benefits and effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis in surgery, cancer and general medicine: a review of the cost-effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Counselling or psychotherapy interventions for patients with a history of sexual or physical assault: patient benefits, harms, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Automation for the preparation of intravenous solutions for acute care patients: cost-effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Sexual Assault Nurse Evaluation (SANE) rape crisis procedure: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Dornase alfa for patients with cystic fibrosis: a review of the clinical efficacy and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Total contact casts for diabetic foot ulcers: cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care testing for human chorionic gonadotropin, creatinine, and blood urea nitrogen: cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Tranexamic acid for the management of bleeding: a review of the clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular therapy for elective and ruptured abdominal aortic aneurysm procedures: a description of utilization trends across Canada
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Codeine and acetylsalicylic acid for the management of post-tonsillectomy or adenoidectomy pain: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Antimicrobial ointments for patients undergoing hemodialysis: a review of evidence-based guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Single-use versus single patient-use electric breast pump kits for the prevention of hospital-acquired infections in mothers and newborns: comparative safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Management of childbirth by midwives: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) External devices for cervical spine immobilization in the pre-hospital setting: clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Removal of intravenous lines following outpatient day procedures: guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Ferumoxytol versus other intravenous iron therapies for anemia: a review of the clinical and cost-effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous ketamine for the treatment of pain syndromes: clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Nabilone for chronic pain: clinical effectiveness, safety, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Nabilone for nausea or vomiting not related to chemotherapy: clinical effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) The prevention of blood-borne infection transmission during immunization: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) The use of spine boards in the pre-hospital setting for the stabilization of patients following trauma: a review of the clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) The emotional freedom technique for the treatment of post-traumatic stress disorder, depression, or anxiety: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Pentazocine versus short-acting opioids for chronic or acute pain: a review of the clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Protease inhibitor use for chronic hepatitis C infection in prior null responders and recurrent hepatitis C infection post liver transplant: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Timing of enoxaparin administration for the prophylaxis of venous thromboembolism: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Single-bed versus multi-bed rooms for the prevention of hospital acquired infections: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Precautionary period for the safe handling of excreta or body fluids in patients receiving cytotoxic or antineoplastic therapy: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Low-molecular weight heparins versus warfarin for the long-term prevention or treatment of deep vein thrombosis or pulmonary embolism: a review of the clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Retesting patients with sleep apnea: guidelines and recommendations
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Hydroxyethyl starch versus other plasma volume expanders: a review of the clinical and cost-effectiveness, and guidelines for use
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Forced air warming units for adults undergoing surgery: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins versus new oral anticoagulants for long-term thrombosis prophylaxis and long-term treatment of DVT and PE: a review of the clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting beta-agonists and inhaled corticosteroids for treatment of chronic obstructive pulmonary disease: a review of the clinical efficacy and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Sleep medications for adults diagnosed with insomnia: clinical evidence and harms
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for sexually transmitted infections: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Brentuximab for refractory CD30+ Hodgkin's lymphoma: clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Administration of anesthesia by anesthesiologists versus non-physicians for patients undergoing cataract surgery: clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Standing tables for adults with cerebral palsy: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Tools and devices for the management of dementia in older adults: review of evidence-based guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Beta human chorionic gonadotropin test for detection of early pregnancy: clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions used to determine the appropriate patient populations for cataract surgery: a review of the clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Antimicrobial drapes for the reduction of surgical site infection: clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Compression bandage measurement devices for the use in adult patients with chronic venous insufficiency: clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Techniques for renal biopsy: guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Peripherally Inserted Central Catheters (PICCs) for adult and pediatric patients: a review of clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D supplementation in long-term care residents: clinical evidence and guidelines